EDGAR Filing Documents for 0000912057-13-000295

Form DRS - Draft Registration Statement:

SEC Accession No. 0000912057-13-000295

Filing Date

2013-09-05

Accepted

2013-09-05 13:41:10

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	DRS	1892265
2		filename2.htm	EX-3.1	145075
3		filename3.htm	EX-3.2	130890
4		filename4.htm	EX-4.2	337183
5		filename5.htm	EX-10.1	69797
6		filename6.htm	EX-10.2	196968
7		filename7.htm	EX-10.10	46058
8		filename8.htm	EX-10.11	73615
9		filename9.htm	EX-10.13	328170
10		filename10.htm	EX-10.14	214814
11		filename11.htm	EX-21.1	2519
12		g190232ky07i001.jpg	GRAPHIC	41652
13		g1009354.jpg	GRAPHIC	13047
14		g190232ky11i001.jpg	GRAPHIC	50390
15		g190232ky15i001.jpg	GRAPHIC	45112
16		g190232kz01i001.gif	GRAPHIC	10130
17		g190232kz05i001.jpg	GRAPHIC	8863
18		g318679.jpg	GRAPHIC	76752
19		g514398.jpg	GRAPHIC	169734
20		g580008.jpg	GRAPHIC	73587
21		g758890.jpg	GRAPHIC	155971
22		g839017.jpg	GRAPHIC	101560
	Complete submission text file	0000912057-13-000295.txt		4468615

Mailing Address 2 MERCER ROAD NATICK MA 01760

Business Address 2 MERCER ROAD NATICK MA 01760 508-975-4820

Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)